Author: OurCrowd

[Velotix in PR Newswire] Velotix secures strategic investment from Barclays Bank and Capri Ventures, cementing position as premier data security platform

May 21, 2024 |

NEW YORK, May 21, 2024 /PRNewswire/ — Velotix, a pioneering provider of a revolutionary AI-driven Data Security Platform (DSP), proudly announces a significant investment from Barclays Bank and Capri Ventures. This investment solidifies Velotix’s position as the premier choice for leading financial institutions seeking advanced data security solutions. It underscores Velotix’s innovative approach to securing structured and unstructured data access and highlights a growing recognition as a transformative force within the data security landscape. Read...

Read More

[Alloy Therapeutics in Startup News] Alloy Therapeutics announces platform license agreement with Lilly

May 21, 2024 |

Alloy Therapeutics, a biotechnology ecosystem company dedicated to democratizing access to biologics drug discovery platforms and services, announced today a licensing agreement for its murine platforms for fully human antibody discovery with Eli Lilly and Company. The non-exclusive license provides Lilly access to the ATX-Gx™ and ATX-CLC™ mouse platforms and broad rights to use the Alloy platforms for antibody drug discovery and development under this multi-year collaboration. Read...

Read More